Navigation Links
Experimental shingles vaccine proves effective in nationwide study

ral medications do not help relieve PHN once it has begun.

The researchers emphasize that the zoster vaccine was tested only as a preventive therapy and is not intended as a treatment for those who already have shingles or postherpetic neuralgia. On April 25, Merck announced that it had submitted a license application to the Food and Drug Administration for the zoster vaccine. If approved for use, the research team estimates the vaccine could prevent 250,000 cases of shingles that occur in the United States each year and significantly reduce the severity of the disease in another 250,000 cases annually.

The study was funded by the VA and by Merck, which supplied the vaccine and placebo. The James R. and Jesse V. Scott Fund for Shingles Research provided additional funds.


'"/>

Source:NIH


Page: 1 2 3 4

Related biology news :

1. NIAID Initiates Trial of Experimental Avian Flu Vaccine
2. Experimental vaccine protects nonhuman primates when given after exposure to Marburg virus
3. Experimental TB drug effective against resistant and latent mycobacterium tuberculosis
4. Experimental drug reverses key cognitive deficits, pathology in Alzheimers
5. Experimental RNA-based drug kills prostate cancer cells effectively and safely
6. Experimental vaccine protects lab animals against several strains of H5N1
7. Experimental vaccine protects mice against deadly 1918 flu virus
8. Experimental cancer drugs counter muscle deterioration seen in muscular dystrophy
9. Experimental vaccine given during pregnancy reduces stillbirths from common virus
10. Research advances quest for HIV-1 vaccine
11. A much-needed shot in the arm for HIV vaccine development
Post Your Comments: